Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
Study NCT ID:
NCT00310232
Status:
TERMINATED
Last Update Posted:
2024-04-02
First Post:
2006-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Sponsor:
Ontario Clinical Oncology Group (OCOG)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-02
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-31
First Submit QC Date:
None
Study First Post Date:
2006-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-01
Last Update Post Date:
2024-04-02
Last Update Post Date Type:
ACTUAL